- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Growth Stocks
Global Pharmaceuticals & Biotech Top Growth Stocks
Results
72
72 companies
Grace Therapeutics
Market Cap: US$42.3m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$3.20
7D
5.6%
1Y
32.8%
Orchid Pharma
Market Cap: ₹36.2b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹712.75
7D
-2.9%
1Y
-52.2%
Arcutis Biotherapeutics
Market Cap: US$2.1b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$17.15
7D
10.5%
1Y
59.2%
CorMedix
Market Cap: US$925.6m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$12.40
7D
-16.4%
1Y
121.4%
AC Immune
Market Cap: US$225.6m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$2.28
7D
11.8%
1Y
-25.2%
Oxford Biomedica
Market Cap: UK£710.3m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£5.91
7D
3.9%
1Y
78.3%
Shanghai Rightongene Biotechnology
Market Cap: CN¥1.6b
Shanghai Rightongene Biotechnology Co., Ltd.
688217
CN¥28.74
7D
-1.6%
1Y
107.7%
GNI Group
Market Cap: JP¥148.4b
Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.
2160
JP¥2,671.00
7D
-0.7%
1Y
27.5%
SK Biopharmaceuticals
Market Cap: ₩8.6t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩109,200.00
7D
10.8%
1Y
4.9%
SIGA Technologies
Market Cap: US$602.9m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$8.42
7D
0.4%
1Y
5.6%
Invivyd
Market Cap: US$222.2m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$1.14
7D
17.2%
1Y
26.5%
Shijiazhuang Yiling Pharmaceutical
Market Cap: CN¥27.4b
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
CN¥16.39
7D
0.06%
1Y
8.0%
BioGaia
Market Cap: SEK 10.5b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 104.10
7D
-1.2%
1Y
-10.1%
Neuphoria Therapeutics
Market Cap: US$22.4m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$11.89
7D
4.9%
1Y
n/a
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 65.60
7D
0.5%
1Y
-16.1%
Ardelyx
Market Cap: US$1.6b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.52
7D
2.5%
1Y
16.4%
Harmony Biosciences Holdings
Market Cap: US$2.1b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$35.99
7D
-2.4%
1Y
1.1%
Iovance Biotherapeutics
Market Cap: US$796.1m
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.
IOVA
US$2.49
7D
11.7%
1Y
-75.1%
BeOne Medicines
Market Cap: US$35.1b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$341.80
7D
11.7%
1Y
78.7%
Krystal Biotech
Market Cap: US$4.3b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$150.27
7D
1.7%
1Y
-19.9%
Unicycive Therapeutics
Market Cap: US$76.3m
A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.
UNCY
US$4.36
7D
4.1%
1Y
23.1%
Evaxion
Market Cap: US$17.0m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$2.92
7D
6.2%
1Y
-83.1%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥18.6b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥11.54
7D
1.9%
1Y
-6.9%
CanSino Biologics
Market Cap: HK$17.3b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$51.90
7D
6.2%
1Y
179.3%
Day One Biopharmaceuticals
Market Cap: US$773.4m
A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$7.55
7D
0.5%
1Y
-46.8%
Earth Science Tech
Market Cap: US$58.9m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.20
7D
0%
1Y
25.0%
Genetic Signatures
Market Cap: AU$63.6m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.28
7D
3.7%
1Y
-60.0%
Japan Tissue Engineering
Market Cap: JP¥20.4b
Engages in the regenerative medicine business in Japan.
7774
JP¥502.00
7D
1.6%
1Y
-4.4%
Journey Medical
Market Cap: US$184.4m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.01
7D
-2.8%
1Y
45.1%
MaaT Pharma
Market Cap: €65.4m
A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.
MAAT
€4.06
7D
-6.2%
1Y
-44.4%
Celcuity
Market Cap: US$2.3b
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$55.69
7D
8.7%
1Y
269.8%
Moberg Pharma
Market Cap: SEK 423.0m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 9.00
7D
10.7%
1Y
-69.3%
Zai Lab
Market Cap: US$3.3b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$30.76
7D
-7.1%
1Y
55.0%
Supriya Lifescience
Market Cap: ₹52.4b
Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.
SUPRIYA
₹651.55
7D
-0.2%
1Y
9.5%
Avadel Pharmaceuticals
Market Cap: US$1.5b
Operates as a biopharmaceutical company in the United States.
AVDL
US$15.76
7D
6.8%
1Y
10.7%
Geron
Market Cap: US$893.2m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.40
7D
0%
1Y
-68.3%